Zagreb, Croatia

Zrinka Ivezić

This inventor holds 1 USPTO granted patent. Top assignee: Pliva, Farmaceutska, Kemijska, Prehrambena I Kozmeticka Industrija, Dionicko Drustvo. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zrinka Ivezić. Retrieved from https://idiyas.com/inventor/zrinka-iveziandcacute

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zrinka Ivezić: Innovator in Antiviral Research

Introduction

Zrinka Ivezić is a notable inventor based in Zagreb, Croatia. She has made significant contributions to the field of antiviral research through her innovative work on coumarin derivatives. Her dedication to scientific advancement is reflected in her patent and her role in the pharmaceutical industry.

Latest Patents

Zrinka holds a patent for "Hydroxy and polyhydroxy derivatives of coumarin, preparation thereof and antiviral action thereof." This invention relates to novel hydroxy and polyhydroxy derivatives of coumarin fused with dialdehydes and aldehyde acids, showcasing her expertise in developing compounds with potential antiviral properties. She has 1 patent to her name.

Career Highlights

Zrinka is currently employed at Pliva, a prominent pharmaceutical, chemical, food, and cosmetic industry company in Croatia. Her work at Pliva has allowed her to engage in cutting-edge research and development, contributing to the advancement of health-related innovations.

Collaborations

Zrinka collaborates with Mladen Trkovnik, enhancing her research efforts and expanding the scope of her projects. Their partnership exemplifies the importance of teamwork in scientific discovery.

Conclusion

Zrinka Ivezić is a pioneering inventor whose work in antiviral research has the potential to impact public health significantly. Her contributions to the field, along with her collaboration with fellow researchers, highlight the importance of innovation in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…